Workflow
Wound Management
icon
Search documents
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
Globenewswire· 2026-03-10 14:30
Core Viewpoint - Smith+Nephew has launched the ALLEVYN COMPLETE CARE Foam Dressing, which incorporates proprietary technologies and is supported by strong scientific data and clinical evidence, aimed at improving wound management and pressure injury prevention [1][4]. Product Features - The ALLEVYN COMPLETE CARE Dressing features a unique five-layer construction designed to minimize leakage and disruption, allowing for fewer dressing changes and better protection of vulnerable skin [2]. - It is proven to lock in significantly more exudate than other foam dressings while keeping over 99% of bacteria away from the wound bed, which minimizes leakage and enables longer wear times for undisturbed healing [5]. - The dressing's unbonded sliding layers absorb up to 93% of mechanical energy, reducing the risk of pressure injury by over 65% [5][6]. Market Context - Global estimates indicate that up to one in 50 adults will experience chronic wounds in their lifetime, with studies showing that up to one in 10 hospitalized patients are affected by pressure injuries, leading to an average of 9.5 additional days in the hospital [3]. - The healthcare system faces significant burdens from pressure injuries and chronic wounds, highlighting the need for effective wound care solutions [3]. Clinical Insights - Rohit Kashyap, President of Advanced Wound Management at Smith+Nephew, emphasized that the ALLEVYN COMPLETE CARE Dressing represents a commitment to innovation in wound care, aiming to reduce clinical burdens and improve patient outcomes [4]. - Amit Gefen, a Professor of Biomedical Engineering, noted that the dressing's design helps dissipate shear forces, protecting soft tissue and minimizing the risk of pressure injuries [6]. Availability and Future Plans - The ALLEVYN COMPLETE CARE Dressing will initially be available in the US, with plans to launch in various European and international markets by 2026 [6].